Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.81 USD | +2.72% | -0.22% | -20.54% |
Business Summary
Number of employees: 712
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-opioid Pain Management and Regenerative Health Solutions
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 56 | Jan. 01 |
Director of Finance/CFO | 63 | 11-10-31 | |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 49 | 21-06-30 |
Anthony Molloy
CMP | Compliance Officer | 50 | - |
Kristen Williams
ADM | Chief Administrative Officer | 50 | 11-11-30 |
Daryl Gaugler
COO | Chief Operating Officer | 62 | 19-05-31 |
Susan Mesco
IRC | Investor Relations Contact | - | 15-03-31 |
Max Reinhardt
PRN | Corporate Officer/Principal | 53 | 19-06-18 |
Corporate Officer/Principal | 52 | 23-04-18 | |
Lauren Riker
PRN | Corporate Officer/Principal | 45 | 12-03-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 76 | 08-05-31 |
Paul Hastings
CHM | Chairman | 64 | 11-06-01 |
Andreas Wicki
BRD | Director/Board Member | 64 | 06-11-30 |
Laura Brege
BRD | Director/Board Member | 66 | 11-06-01 |
Director/Board Member | 69 | 13-06-11 | |
Alethia Young
BRD | Director/Board Member | 45 | 23-10-09 |
Marcelo Bigal
BRD | Director/Board Member | - | 23-10-09 |
Mark Froimson
BRD | Director/Board Member | 63 | 17-06-14 |
Frank Lee
CEO | Chief Executive Officer | 56 | Jan. 01 |
Director/Board Member | 61 | 19-09-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,500,778 | 45,935,591 ( 98.78 %) | 0 | 98.78 % |
Company contact information
Pacira Biosciences, Inc.
5401 West Kennedy Boulevard Suite 890
33609, Tampa
+813 553 6680
http://www.pacira.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.54% | 1.25B | |
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- PCRX Stock
- Company Pacira BioSciences, Inc.